Considering that the expression of miR-26 family is frequently reduced in multiple types of cancer[15-19], we suggest that miR-26b downregulation may represent one of the mechanisms responsible for the overexpression of TAK1 and TAB3 in cancers. This evidence concerns the gene MAP3K7 and cancer.